(請(qǐng)按提綱填寫(xiě)) 1.科研項(xiàng)目 1).山西省自然科學(xué)基金:奈比洛爾改善2型糖尿病大鼠血管內(nèi)皮胰島素抵抗的作用及機(jī)制(201901D111199) 2).國(guó)家自然科學(xué)基金青年基金:奈比洛爾非血壓依賴性高血壓腎病保護(hù)作用的分子機(jī)制(81503075) 3).山西省回國(guó)留學(xué)人員科研資助項(xiàng)目:奈必洛爾調(diào)節(jié)腎ADMA改善高血壓腎病的研究(2017-057) 4).山西省回國(guó)留學(xué)人員科技活動(dòng)擇優(yōu)資助項(xiàng)目:奈必洛爾對(duì)STZ致糖尿病大鼠腎損傷的保護(hù)作用及機(jī)制(2018-10) 2.學(xué)術(shù)論文 1)Li X, Li Q, Wu L, Wang Y*. Nebivolol Alleviates Vascular Endothelial Insulin Resistance by Inhibiting Endoplasmic Reticulum Stress. Int Heart J 2023 Mar 31;64(2):283-293. 2)李秋萍,,武利軍,,王燕. 奈比洛爾對(duì)血管內(nèi)皮細(xì)胞胰島素抵抗的影響. 中國(guó)臨床藥理學(xué),,2022,38(13):1448-1451. 3)武利軍,,李馨,,崔麗娟,李欣欣,,王燕. 基于蛋白質(zhì)組學(xué)分析奈比洛爾改善 UUO大鼠腎間質(zhì)纖維化. 中國(guó)臨床藥理學(xué)與治療學(xué),,2022,27(7):729-738. 4)Wang Y#*, Niu M#, Yin S, Zhang F, Shi R. Nephroprotective effects of nebivolol in 2K1C rats through regulation of the kidney ROS-ADMA-NO pathway. Pharmacological reports. 2018, 70(5):917-929. 5)Wang Y#*, An W#, Zhang F, Niu M, Liu Y, Shi R. Nebivolol ameliorated kidney damage in Zucker diabetic fatty rats by regulation of oxidative stress/NO pathway: Comparison with captopril. Clinical and experimental 3.學(xué)術(shù)榮譽(yù) 4.科技獎(jiǎng)勵(lì) 5.發(fā)明專利 6.學(xué)術(shù)任職 |